SOURCES SOUGHT
A -- Sources Sought to identify qualified subcontractors to perform phase 1/2 viral project in support of clinical trials
- Notice Date
- 6/16/2005
- Notice Type
- Sources Sought
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bldg 427, Room 12, Frederick, MD, 21702
- ZIP Code
- 21702
- Solicitation Number
- S05-079
- Response Due
- 6/29/2005
- Archive Date
- 6/29/2005
- Description
- This announcement constitutes a Sources Sought Synopsis. Responses to this publication are solicited to identify qualified sources. Contractors expressing an interest should provide appropriate capability statements. Capability statements should include a description of the organization?s experience and past performance as it relates to the work described herein. CV?s for key personnel should be included in the capability statement. Interested contractors shall also provide (1) an outline of specific work previously performed or being performed; (2) the professional qualifications and specific experience of staff who may be assigned to the requirement (3) any other specific and pertinent information as pertains to this Sources Sought Notice that would enhance our consideration and evaluation of the information submitted. Responses must reference Request for Information (RFI) number S05-079 and include the following: (1) name and address of firm, (2) type of business (i.e.: small business, small disadvantaged 8(a) certified, woman-owned small business, small disadvantaged business (not 8(a) certified), verteran-owned small business, etc.) (3) two points of contact: name, title, phone, fax and e-mail, (4) DUNS number, (5) contractor?s capabilities statement: relevant work including a summary of work performed, contract number, contract type, dollar value for each customer, reference and customer point of contact with phone number. Responses shall be submitted via e-mail to: Melayne A.C. Richards at mrichards@ncifcrf.gov not later than Noon (EDT) June 29, 2005. Statement of Work The Biopharmaceutical Development Program (BDP) located at the National Cancer Institute at Frederick, Maryland is attempting to identify qualified vendors to perform a fixed priced or cost reimbursable contract for a Phase I/II viral project in support of clinical trials. This project has not yet been funded. Should this project be authorized, the qualified vender will perform the following work under CGMP guidelines and the Biopharmaceutical Development Program Quality Agreement (to be struck concurrent to a subsequent subcontract): Production of a master virus bank, toxicology lot, and a CGMP clinical lot-via cell factory, cell cube technology or any other potential state-of-the-art viral production technology. Vendor will perform the work using a vaccinia virus. A detailed statement of work will be provided should funding for this project be allocated. THIS SYNOPSIS IS FOR INFORMATION AND PLANNING PURPOSES AND IS NOT TO BE CONSTRUED AS A COMMITMENT BY SAIC-FREDERICK OR THE GOVERNMENT. THIS IS NOT A SOLICITATION ANNOUNCEMENT FOR PROPOSALS AND NO CONTRACT WILL BE AWARDED FROM THIS ANNOUNCEMENT. NO REIMBURSEMENT WILL BE MADE FOR ANY COSTS ASSOCIATED WITH PROVIDING INFORMATION IN RESPONSE TO THIS ANNOUNCEMENT AND ANY FOLLOW-UP INFORMATION REQUESTS. ALL INFORMATION SUBMITTED IN RESPONSE TO THIS ANNOUNCEMENT MUST ARRIVE ON OR BEFORE THE CLOSING DATE. THE CLOSING DATE FOR RESPONSES IS NOON (EDT) JUNE 29, 2005.
- Place of Performance
- Address: Subcontractor's facility
- Record
- SN00831029-W 20050618/050616211848 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |